Chemours Company (the) · NYSE:CC

Chemours Company (the) — The Chemours Company — Q2 2026 Earnings Presentation

26 slides from Chemours Company (the)'s earnings presentation, Aug 5, 2026

  1. Slide 1: Q2 2026 Earnings Presentation

    Q2 2026 EARNINGS PRESENTATION August 5, 2026

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current exp

  3. Slide 3: Second Quarter 2026 Highlights

    Second Quarter 2026 Highlights Generated $1.6B in Net Sales and $247M in Adjusted EBITDA, supported by strong performance across all segments Announced global TiO2 price increase effective June 1, 2026, as a continuation of December & April price actions; achieved a YTD TiO2 price increase of 5% APM

  4. Slide 4: Second Quarter 2026 Financial Summary

    Second Quarter 2026 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 2Q26 2Q25 Y-o-Y ∆ 1Q26 Q-o-Q ∆ Net Sales $1,591 $1,615 ($24) $1,381 $210 Net (Loss) / Income1 ($274) ($380) $106 ($29) ($245) Adj. Net Income 2 $64 $91 ($27) $8 $56 EPS 3 ($1.81) ($2.53) $0.72 ($

  5. Slide 5: Adjusted EBITDA Bridge: 2Q26 versus 2Q25

    Adjusted EBITDA Bridge: 2Q26 versus 2Q25 ($ in millions) $35 ($33) ($23) $8 $260 $247 2Q25 Price Volume Cost/Other Currency 2Q26 Price Impacts: $35 million due to higher pricing across the three primary segments, with strength in TiO2 pricing tied to the three disclosed pricing actions since Decembe

  6. Slide 6: Quarterly Segment Summary

    Quarterly Segment Summary ($ in millions unless otherwise noted) Net Sales TSS TT APM $519 $596 $591 $677 $657 $661 $345 $346 $326 2Q24 2Q25 2Q26 2Q24 2Q25 2Q26 2Q24 2Q25 2Q26 Adjusted EBITDA and Margin (%) TSS TT APM $160 $207 $213 $83 $47 $48 $45 $50 $26 2Q24 2Q25 2Q26 2Q24 2Q25 2Q26 2Q24 2Q25 2Q2

  7. Slide 7: Liquidity Position as of June 30, 2026

    Liquidity Position as of June 30, 2026 ($ in millions unless otherwise noted) Total Liquidity 7 $1.6B Gross Debt $3.9B Net Debt 8 $3.2B TTM Net Leverage 9 4.4x $723 $52 Restricted $615 ($44) ($13) $7 $53 Restricted $158 $671 $562 Unrestricted Unrestricted 5 6 5 1Q26 Cash Balance Operating Cash Flows

  8. Slide 8: Strategic Progress

    STRATEGIC PROGRESS PATHWAY TO THRIVE

  9. Slide 9: Our Strategy

    Our Strategy PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ❑Manufacturing excellence as a basis for success ❑Investing smartly in selected ❑Holistic portfolio analysis ❑Measurable progress on growth projects focused on distinct value resolv

  10. Slide 10: Progress Achieved to Date

    Progress Achieved to Date PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ✓ Notable progress against the ✓ Recorded initial sales of less than ✓ Progressed APM European asset ✓ Reached a settlement with the EPA $250M of run-rate savings by en

  11. Slide 11: Established Participation Focused on AI Infrastructure

    Established Participation Focused on AI Infrastructure Data Center Use Cases Semiconductor Fabrication Use Cases Thermal Management ➢ Opteon and Freon refrigerants support current cooling infrastructure ➢ Insulation and coatings for temperature and humidity control Performance Materials ➢ Teflon mat

  12. Slide 12: Expanding Applications & R&D Priorities for AI Infrastructure

    Expanding Applications & R&D Priorities for AI Infrastructure Two-Phase Direct to Chip Two-Phase Immersion Cooling 1 1 Liquid thermal management fluids circulate 3 1 Electronic equipment is submerged in into the server rack manifold through a Opteon 2P50 in a sealed container, closed loop system all

  13. Slide 13: Third Quarter Guidance

    Third Quarter GUIDANCE

  14. Slide 14: Third Quarter and Full Year 2026 Guidance

    Third Quarter and Full Year 2026 Guidance Sequential Business Outlook: Third Quarter 2026 Outlook Full Year 2026 Outlook  Consolidated o Net Sales: Expected to decrease in the (5%) to 0% range sequentially o Adjusted EBITDA: Expected to range between $175 million and $205 million o Corporate Expens

  15. Slide 15: Appendix

    APPENDIX 15

  16. Slide 16: TSS Segment Net Sales and Adjusted EBITDA (Unaudited)

    TSS Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) % of total Net Sales $597 $591 FP&O FP&O 17% $20 $(26) 18% FreonTM FreonTM Refrig. 21% Refrigerants 25% 2Q25 % total 2Q26 % total refrigerants: refrigerants: OpteonTM Freon = 25% Freon = 31% $207 $213 Opteon = Opte

  17. Slide 17: TT Segment Net Sales and Adjusted EBITDA (Unaudited)

    TT Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) $657 $661 Minerals 4% Minerals 3% $19 $(15) TiO2 TiO2 96% 97% $47 $48 2Q25 Price/Currency Volume 2Q26 2Q25 Price/Currency Volume Cost/Other 2Q26 Net Sales: The increase was driven by a 2% increase in global pricing

  18. Slide 18: APM Segment Net Sales and Adjusted EBITDA (Unaudited)

    APM Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) % of total Net Sales $346 $326 $11 Performance ($32) Solutions Performance 38% Solutions 44% Advanced Advanced Materials Materials $50 62% 56% $26 2Q25 Price/Currency Volume 2Q26 2Q25 Price/Currency Volume Cost/Oth

  19. Slide 19: Segment Net Sales (Unaudited)

    Segment Net Sales (Unaudited) 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Net sales by product group and segment OpteonTM refrigerants $ 200 $ 227 $ 205 $ 178 $ 279 $ 375 $ 368 $ 243 $ 313 $ 337 TM Freon refrigerants 173 173 146 124 97 123 98 113 162 150 Foam, propellants, and other 81 119 117 88 9

  20. Slide 20: Segment Net Sales by Region (Unaudited)

    Segment Net Sales by Region (Unaudited) 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Net sales by geographic region North America: Thermal & Specialized Solutions $ 271 $ 308 $ 256 $ 194 $ 233 $ 336 $ 316 $ 241 $ 326 $ 340 Titanium Technologies 246 274 270 236 267 282 252 221 235 267 Advanced Perfor

  21. Slide 21: Segment Net Sales and Adjusted EBITDA (Unaudited)

    Segment Net Sales and Adjusted EBITDA (Unaudited) 2024 2025 2026 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Segment Net Sales Thermal & Specialized Solutions $ 454 $ 519 $ 468 $ 390 $ 466 $ 597 $ 560 $ 444 $ 568 $ 591 Titanium Technologies 592 676 672 632 597 657 612 561 559 661 Advanced Performance Materia

  22. Slide 22: GAAP Net Income to Adjusted Net Income and Adjusted EBITDA Reconciliation (1/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended June 30, March 31

  23. Slide 23: GAAP Net Income to Adjusted Net Income and Adjusted EBITDA Reconciliation (2/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 2/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended June 30, March 31

  24. Slide 24: GAAP Operating Cash Flow to Free Cash Flows and Conversion Reconciliation

    GAAP Cash Flow Provided by Operating Activities to Free Cash Flows and Free Cash Flow Conversion Reconciliation Three Months Ended Six Months Ended June 30, March 31, June 30, 2026 2025 2026 2026 2025 Cash flows (used for) provided by operating activities $ 158 $ 93 $ (44) $ 114 $ (19) Less: Purchas

  25. Slide 25: 2026 Estimated GAAP to Adjusted Reconciliations

    2026 Estimated GAAP Net Income Attributable to Chemours to Estimated Adjusted Net Income and Estimated Adjusted EBITDA Reconciliation; 2026 Estimated GAAP Cash Flow Provided by Operating Activities to Estimated Free Cash Flows and Estimated Free Cash Flow Conversion Reconciliation 25 Chemours - Inte

  26. Slide 26: © 2026 Chemours. All Rights Reserved

    ® 2026 CHEMOURS. ALL RIGHTS RESERVED​

The Chemours Company — Q2 2026 Earnings Presentation on 6ix